Hyperice Valuation, Funding & Investors

Hyperice is valued at $700M as of October 2020.

Last Hyperice valuation

$700M

Series A · Oct 2020

Last Hyperice funding round

Strategic investment

Amount undisclosed · Nov 2021

Cumulative funding Hyperice raised

$48M

across 2 funding rounds

Key investors in Hyperice

  • Main Street Advisors
  • Symphony Ventures
  • SC.Holdings

Hyperice Overview

About Hyperice

Hyperice is a Carlsbad, California-headquartered company manufacturing percussion massage devices, compression boots, and thermal wearables for athletic recovery. Its Hypervolt line delivers targeted vibration therapy up to 3,200 percussions per minute, adopted by over 400 professional sports teams including NBA's Los Angeles Lakers and NFL's New England Patriots. Founded in 2012, Hyperice expands into consumer fitness with Normatec recovery systems used in Olympic training facilities worldwide.


Founded

2011

HQ

United StatesLos Angeles, CA

Status

Privately held

Customer focus

B2C

Revenue model

Product sales

Valuation

$700M (Oct 2020)

Hyperice Valuation

Hyperice is currently valued at $700M, based on its Series A in October 2020.

The $48M round was led by Main Street Advisors and SC.Holdings.

Hyperice valuation by funding round

Hyperice valuation by funding round
DateStageValuation
Oct 2020Series A$700M

Hyperice Funding History

Hyperice has raised a total of $48M across 2 funding rounds.

Hyperice's first fundraising round was a $48M Series A in October 2020. The most recent completed round was a strategic investment round in November 2021.

Hyperice funding rounds

Hyperice funding rounds
DateStageInvestorsRaisedValuationDeal Summary
Nov 2021Strategic investmentSymphony Ventures--Hyperice announced in November 2021 that Rory McIlroy, investing through his firm Symphony Ventures, had become a strategic investor in the company alongside Formula One driver Daniel Ricciardo, ice hockey player Connor McDavid and basketball players Klay Thompson and Jayson Tatum. The amount invested and the stakes acquired were not disclosed. The new backers joined an existing group of athlete-investors that included Naomi Osaka, Erling Haaland and Virat Kohli, and Hyperice said the investments were intended to support international growth and the company's move from recovery hardware into broader high-performance wellness, including mental wellness products. Chief executive Jim Huether framed the athletes as strategic partners for product development and brand reach rather than purely financial investors. Hyperice makes percussive massage devices, vibrating rollers, compression boots and contrast therapy products, selling to consumers through retail and e-commerce and to professional teams, hotels and healthcare providers. The company was founded in 2010 by Anthony Katz, is based in Irvine, California, had raised a $48 million round in 2020, and reported gross revenue above $200 million in 2020 with products distributed in more than 60 countries.
Oct 2020Series AMain Street Advisors (lead); SC.Holdings (lead)$48M$700MHyperice is an Irvine, California-based developer of recovery technology devices including percussion, vibration, dynamic air compression, and thermal technology designed to help athletes and fitness enthusiasts recover after workouts and competition. The company pioneered percussion massage technology and has built a suite of connected fitness products under its HyperSmart platform. In October 2020, Hyperice closed a $47.8 million Series B funding round led by Main Street Advisors and SC.Holdings, a private equity firm focused on sports and entertainment, valuing the company at $700 million post-money. The round included strategic investments from the NFL's investment arm 32 Equity, the NBA, OneTeam (representing players' associations across baseball, basketball, soccer, football, and tennis), and prominent athletes including Anthony Davis, Naomi Osaka, Patrick Mahomes, and Chris Paul. Hyperice founder Anthony Katz highlighted that bringing athletes on as investors reflected their authentic connection to the brand and daily usage of the products. The company stated it would deploy capital toward expanding AI capabilities, global expansion, increasing sales and marketing efforts, and product development. At the time of the round, Hyperice had raised only $4.5 million total in the decade since its founding, with the previous valuation five years prior having been $10 million, representing significant growth momentum. CEO Jim Huether indicated the company's ambition to become a multibillion-dollar enterprise and noted that an initial public offering was potentially in the company's future, though not imminent.

Who has invested in Hyperice?

3 investors have backed Hyperice across its funding rounds, including Main Street Advisors, Symphony Ventures and SC.Holdings.

Lead investors include Main Street Advisors and SC.Holdings.


Hyperice Investors

Investors in Hyperice by funding rounds participated
InvestorHQRoundsRoleFirst check
Symphony VenturesIrelandDublin1ParticipantNov 2021

This data is available for Pro users. Sign up to see all 3 Hyperice investors.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

Acquisitions by Hyperice

Hyperice has acquired 3 companies to date.

Last acquisition by Hyperice was on July 27th 2021. Hyperice acquired Core for undisclosed valuation.


Latest Acquisitions by Hyperice

Core
RecoverX
NormaTec Recovery
Description
Core is a San Francisco-headquartered company developing haptic meditation devices integrated with the Hyperice brand. Its technology combines biofeedback sensors and vibration patterns to deliver guided meditation sessions for stress reduction, relaxation, and improved sleep. The wearable device tracks user progress through app-connected metrics and personalizes routines based on physiological responses.
-
NormaTec Recovery is a pioneer in dynamic air compression systems for athletic recovery and rehabilitation. The company manufactures the NormaTec PULSE Recovery Systems, featuring attachments for legs, arms, and hips that deliver sequential pulsing compression to enhance circulation and reduce soreness. These devices incorporate pre-inflate cycles to customize fit and mimic manual massage patterns from distal to proximal zones. NormaTec systems serve professional sports teams in the NFL, NBA, and MLB, as well as Olympic athletes from the 2014 Sochi Games. Headquartered in Andover, Massachusetts, NormaTec Recovery joined Hyperice in 2020 to expand its global reach in sports performance technology.
HQ CountryUnited StatesUnited StatesUnited States
HQ City
San Francisco, CA
-
Boston, MA
Deal Date27 Jul 202127 Jan 20215 Mar 2020
Valuationundisclosedundisclosedundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Hyperice acquisitions and their M&A valuation multiples.

Start Free Trial

Hyperice Competitors

Hyperice competitors include listed companies like MiMedx Group, UltraGreen.ai and Sunmax Biotechnology, and private ones like SiBionics, Galvanize Therapeutics and Carestream.

Public and private companies comparable to Hyperice
CompanyHQStatusRevenueEBITDAValuationRevenue Multiple
MiMedx GroupUnited StatesUnited StatesPublicly listed$419M$78M$684M1.8x
SiBionicsChinaChinaPrivate--$717M-
UltraGreen.aiSingaporeSingaporePublicly listed$138M$78M$672M2.9x
Sunmax BiotechnologyTaiwanTaiwanPublicly listed$64M$35M$670M-
Galvanize TherapeuticsUnited StatesSan Francisco, CAPrivate--$650M-
CarestreamChinaShanghaiPrivate--$800M-

Hyperice Public Comps

Hyperice is still privately-owned, but its public comps include Star Sports Medicine, Japan Lifeline, Mesa Laboratories, Barco, MiMedx Group, Cytek Biosciences, UltraGreen.ai, Sunmax Biotechnology, Shua Fitness and SS Innovations.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
Star Sports Medicine$60M$24M9.0x-22.0x-
Japan Lifeline$381M$89M1.8x1.7x7.5x7.7x
Mesa Laboratories$249M$46M3.3x3.3x18.0x13.2x
Barco$1.1B$141M0.7x0.6x5.2x5.3x
MiMedx Group$419M$78M1.4x1.8x7.2x21.0x
Cytek Biosciences$201M($24M)2.2x2.1x(18.4x)(78.1x)
UltraGreen.ai$138M$78M3.4x2.9x6.1x4.7x
Sunmax Biotechnology$64M$35M10.2x-18.6x-

This data is available for Pro users. Sign up to see all Hyperice competitors and their valuation data.

Start Free Trial

Common questions about Hyperice

When was Hyperice founded?Hyperice was founded in 2011.
Where is Hyperice headquartered?Hyperice is headquartered in Los Angeles, CA, United States.
Is Hyperice publicly listed?No, Hyperice is a private, VC-backed company.
What is Hyperice's valuation?Hyperice was last valued at $700M in its Series A in October 2020.
How much funding has Hyperice raised?Hyperice has raised $48M across 2 funding rounds.
What was Hyperice's last funding round?Hyperice's last funding round was a strategic investment round in November 2021.
Who are Hyperice's investors?Hyperice's investors include Symphony Ventures, SC.Holdings and Main Street Advisors.
Which companies are comparable to Hyperice?Companies comparable to Hyperice include MiMedx Group, SiBionics, UltraGreen.ai, Sunmax Biotechnology, Galvanize Therapeutics and Carestream.
How many companies has Hyperice acquired?Hyperice has acquired 3 companies, including Core, RecoverX and NormaTec Recovery.

See companies similar to Hyperice

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial